EUVIMEDEUVIMED entdecken
Crossref

LC–MS‐Guided Identification of Bioactive Constituents in Qingfei Jiedu Huatan Formula Reveals Ginsenoside Rb1 as an Endothelial Barrier‐Protective Compound Targeting PAI‐1 in Pneumonia

Peng Zhao iD, Xinguang Liu, Xiaoxiang Xing, Yuhang Jiang, Furong Jia, Ziying Chen, Jianwei Wang, Jiansheng Li iD

Phytochemical Analysis · 22.08.2026

DOI: 10.1002/pca.70087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytochemical Analysis, online erschienen am 22.08.2026. Verfasst von Peng Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of P.R. China/Hen…. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Henan University Science and Technology Innovation Talent Support Program, Training Program for Young Core Faculty in Undergraduate Universities in Henan Province, Natural Science Foundation of Henan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Qingfei Jiedu Huatan Formula (QJHF) is a traditional Chinese medicine formula developed for severe pneumonia with the syndrome of “phlegm heat obstructing the lung.” Purpose This study aimed to investigate the protective effects and underlying mechanisms of QJHF on pulmonary vascular endothelial barrier dysfunction in severe pneumonia. Materials and Methods Mouse models of pneumonia/lung injury were established by intratracheal instillation of Klebsiella pneumoniae or LPS to evaluate the protective effects of QJHF. A novel strategy integrating LC–MS‐based serum pharmacochemistry and single‐cell RNA sequencing was performed to elucidate the underlying mechanisms of QJHF. An LPS‐induced HUVEC endothelial barrier injury model was used to screen active compounds and investigate their mechanisms of action.

Results

QJHF markedly alleviated lung injury and inflammatory responses in mice challenged with Klebsiella pneumoniae or LPS. Specifically, QJHF reduced inflammatory cell infiltration, particularly neutrophil accumulation, decreased the levels of IL‐1β, IL‐6, and TNF‐α, and suppressed pulmonary myeloperoxidase activity. Single‐cell transcriptomic analysis revealed that QJHF mainly modulated inflammatory responses and vascular endothelial function. Moreover, QJHF decreased the lung index, lung wet/dry weight ratio, total protein concentration, and Evans blue extravasation, while restoring VE‐cadherin expression, indicating preservation of pulmonary endothelial barrier integrity. Integrated serum component profiling and network pharmacology analyses identified 10 major absorbed constituents that may underlie the endothelial barrier‐protective effects of QJHF. Among these constituents, ginsenoside Rb1 (G‐Rb1) was identified as a key bioactive component. G‐Rb1 upregulated VE‐cadherin expression and protected endothelial barrier integrity both in vitro and in vivo and further ameliorated LPS‐induced lung tissue injury and inflammatory responses in mice. Target identification further implicated plasminogen activator inhibitor‐1 (PAI‐1) as a putative molecular target of G‐Rb1, which was subsequently validated by molecular dynamics simulations, cellular thermal shift assays, and surface plasmon resonance analysis. Importantly, PAI‐1 overexpression attenuated the protective effects of G‐Rb1 on endothelial barrier function.

Conclusion

QJHF ameliorates inflammatory lung injury in pneumonia mice by preserving the pulmonary vascular endothelial barrier. This effect is at least partly mediated by G‐Rb1, which targets and suppresses PAI‐1, thereby restoring VE‐cadherin‐mediated endothelial junction integrity.

Schlagwörter

Stichwörter der Autor:innen

PAI‐1Qingfei Jiedu Huatan FormulaUPLC‐TOF‐MSendothelial barrierpneumoniaserum pharmacochemistry

Autor:innen und Institutionen

  • Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province & Education Ministry of P.R. China/Henan Key Laboratory of Chinese Medicine for Respiratory Diseases, Henan…
  • Lung Disease Diagnosis and Treatment Center, National Medical Center, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.

ORCID-Profile: Peng Zhao, Jiansheng Li

Förderung

  • Henan University Science and Technology Innovation Talent Support Program
  • Training Program for Young Core Faculty in Undergraduate Universities in Henan Province
  • Natural Science Foundation of Henan
  • National Key Research and Development Program of China

Zitieren

APA

Zhao, P., Liu, X., Xing, X., Jiang, Y., Jia, F., Chen, Z., Wang, J., & Li, J. (2026). LC–MS‐Guided Identification of Bioactive Constituents in Qingfei Jiedu Huatan Formula Reveals Ginsenoside Rb1 as an Endothelial Barrier‐Protective Compound Targeting PAI‐1 in Pneumonia. Phytochemical Analysis. https://doi.org/10.1002/pca.70087

Vancouver

Zhao P, Liu X, Xing X, Jiang Y, Jia F, Chen Z, et al. LC–MS‐Guided Identification of Bioactive Constituents in Qingfei Jiedu Huatan Formula Reveals Ginsenoside Rb1 as an Endothelial Barrier‐Protective Compound Targeting PAI‐1 in Pneumonia. Phytochemical Analysis. 2026. doi:10.1002/pca.70087

BibTeX
@article{Zhao2026,
  author = {Zhao, Peng and Liu, Xinguang and Xing, Xiaoxiang and Jiang, Yuhang and Jia, Furong and Chen, Ziying and Wang, Jianwei and Li, Jiansheng},
  title = {LC–MS‐Guided Identification of Bioactive Constituents in Qingfei Jiedu Huatan Formula Reveals Ginsenoside Rb1 as an Endothelial Barrier‐Protective Compound Targeting PAI‐1 in Pneumonia},
  journal = {Phytochemical Analysis},
  year = {2026},
  doi = {10.1002/pca.70087}
}
Kostenlos starten →